Numinus Wellness Parts With Chief Strategy Officer, Issues 2.0 Million Shares With Separation

Numinus Wellness Inc. (TSXV: NUMI) announced on Thursday that its Chief Strategy Officer Stacey Wallin is leaving the company. The responsibilities of the position have been currently transitioned “across [the firm’s] leadership team”.

As part of the separation agreement, the company is issuing to Wallin 2.0 million common shares from treasury. Based on the company’s last trading price, this is approximately valued at $1.2 million.

The wellness firm announced yesterday the departure following “the conclusion of several weeks of discussions”. On the other hand, Wallin’s LinkedIn account shows her term ended as early as August 2021.

“During Stacey’s three years with Numinus, she was integral to the development of foundational operations necessary to support the growth of Numinus,” said Numinus CEO Payton Nyquvest.

Numinus Wellness last traded at $0.59 on the TSX Venture.


Information for this briefing was found via Numinus Wellness. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Silver’s Finally Breaking the System | Keith Neumeyer – First Majestic

The Best News for Gold Was the Drop! – Peter Grandich

McEwen Copper: The Los Azules Feasibility Study

Recommended

Silver47 Completes Property-Wide Geochemical, Rock Sampling Program At Adams Plateau, Identifies Numerous Targets

Altamira Gold Identifies Presence Of Second Mineralized Porphyry Body At Cajueiro

Related News

Numinus Wellness To Conduct $30 Million Bought Deal

Numinus Wellness (TSXV: NUMI) this morning announced that it will be raising funds again. The...

Monday, March 15, 2021, 09:27:11 AM

Numinus Wellness Walks From Acquisition Of MedBright AI

Numinus Wellness (TSX: NUMI) has walked away from a plan to add artificial intelligence assets...

Monday, August 12, 2024, 10:08:35 AM

Numinus Wellness To Conduct $10.0 Million Bought Deal

Numinus Wellness (TSXV: NUMI) evidently is seeing strong investor demand, with the psychedelics firm this...

Monday, December 7, 2020, 07:38:26 AM

Numinus Wellness’ Study On MDMA-Assisted Therapy For PTSD Gets Health Canada Nod

Numinus Wellness Inc. (TSXV: NUMI) announced today that it has secured approval from Health Canada...

Monday, July 12, 2021, 09:49:00 AM

Numinus Wellness: Eight Capital Initiates With $1.10 Price Target

Last week, Eight Capital launched coverage on a basket of psychedelic companies. This comes after...

Monday, September 20, 2021, 02:41:00 PM